ConvaTec Group (LON:CTEC)‘s stock had its “hold” rating reissued by stock analysts at Numis Securities in a report issued on Thursday. They presently have a GBX 180 ($2.49) price objective on the stock. Numis Securities’ price objective indicates a potential downside of 12.32% from the company’s previous close.

CTEC has been the subject of a number of other reports. Peel Hunt reissued a “hold” rating and issued a GBX 250 ($3.45) price target on shares of ConvaTec Group in a research report on Thursday, February 1st. Deutsche Bank reissued a “sell” rating and issued a GBX 180 ($2.49) price target on shares of ConvaTec Group in a research report on Friday, December 1st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of GBX 245.78 ($3.40).

Shares of ConvaTec Group (LON CTEC) opened at GBX 205.30 ($2.84) on Thursday. ConvaTec Group has a 1 year low of GBX 181.40 ($2.51) and a 1 year high of GBX 349.10 ($4.82). The firm has a market cap of $3,770.00 and a price-to-earnings ratio of -1,866.36.

In other ConvaTec Group news, insider Ros Rivaz acquired 4,821 shares of the company’s stock in a transaction on Wednesday, December 6th. The shares were bought at an average cost of GBX 206 ($2.85) per share, for a total transaction of £9,931.26 ($13,721.00).

TRADEMARK VIOLATION WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at

ConvaTec Group Company Profile

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Analyst Recommendations for ConvaTec Group (LON:CTEC)

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with's FREE daily email newsletter.